Les meilleurs doctors en en Israël - TOP-16 des médecins

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.

She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.

Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.

Le Dr Grisaro Galia dirige le service des maladies infectieuses pédiatriques à l'hôpital pour enfants Dana-Dwek – se spécialisant exclusivement dans les cas pédiatriques.

• Rôle de niveau directeur dans un hôpital pédiatrique de premier plan
• Formée à l'Université de Toronto – un leader mondial de la recherche sur les maladies infectieuses
• Détient un diplôme Marze Bachir en maladies infectieuses pédiatriques
• Se concentre sur les cas infectieux pédiatriques complexes

Le Dr Katsman est spécialisé dans la prise en charge du VIH au centre médical Sourasky, avec plus de 25 ans d'expérience dans le domaine des maladies infectieuses.

• Médecin titulaire principal au centre médical Sourasky de Tel Aviv
• Formation avancée au McGill AIDS Centre à Montréal
• Membre de l'International AIDS Society et de l'European AIDS Clinical Society
• Affilié au Crusaid Kobler AIDS Center

Le professeur Eli Sprecher dirige le service de dermatologie du centre médical Sourasky de Tel Aviv, en se concentrant sur les maladies génétiques de la peau.

• Spécialisé en génétique dermatologique à l'université Thomas Jefferson
• Auteur de plus de 220 publications scientifiques en dermatologie
• Membre de sociétés clés, dont l'American Academy of Dermatology
• Professeur au Technion – Institut de technologie d'Israël

Figurant dans la liste 2021 de Forbes des meilleurs médecins d'Israël, le Prof. Kivity est spécialisé en allergologie et immunologie au centre médical Sourasky.

• Expert dans le diagnostic et le traitement des allergies, de l'asthme et de la rhinite allergique
• Membre de plusieurs sociétés internationales d'allergologie et d'immunologie
• Formé dans des institutions prestigieuses, dont le National Jewish Hospital
• Lauréat de plusieurs prix de recherche en immunologie

Chef du service de rhumatologie au Sourasky Medical Center – Le Dr Kaspy se spécialise dans les cas complexes et dirige les programmes de spécialisation en rhumatologie d'Israël.

• A effectué un stage prestigieux à l'Hammersmith Hospital de Londres
• Ancien chef de l'hôpital de jour en rhumatologie à Ichilov
• Plus de 140 publications scientifiques sur la rhumatologie
• Membre des associations de rhumatologie israélienne et américaine

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

À la tête du département d'hématologie du centre médical Hadassah, le professeur Dina Ben-Yehuda intègre l'immunologie et la thérapie génique de pointe pour les maladies du sang.

• Professeur avec plus de 25 ans d'expérience en hématologie et immunologie
• Pionnière des greffes de moelle osseuse et de la thérapie génique
• Formée au Memorial Sloan-Kettering Cancer Center à New York
• Première femme doyenne de la faculté de médecine Hadassah
• Lauréate de plusieurs prix prestigieux pour les soins aux patients

Le Dr Dimitrios Karussis dirige la clinique multidisciplinaire de la sclérose en plaques au centre médical Hadassah avec plus de 30 ans d'expérience en neuro-immunologie.

• Spécialisé en neuro-immunologie et en transplantation de moelle osseuse
• Responsable du laboratoire EAE à Hadassah
• Membre du « Steering Committee » européen pour la transplantation de moelle osseuse
• Doctorat en neuro-immunologie/neurobiologie

Le Dr Michael Lotem dirige le Centre d'immunothérapie du mélanome et du cancer du centre médical Hadassah, où il met au point de nouveaux traitements contre le mélanome.

• Spécialisé dans l'immunothérapie pour le traitement du cancer
• Étudie les récepteurs SLAM dans les réponses immunitaires anticancéreuses
• Combine la pratique clinique et la recherche translationnelle
• L'équipe comprend des cliniciens et des chercheurs de haut niveau

Professor Pnina Langevich is a rheumatologist and immunologist with over 40 years of experience. She leads the National Center for Rheumatology and Autoimmune Diseases at Sheba Medical Center. Forbes Israel has repeatedly named her among the country’s top doctors.

She is an expert in rheumatoid arthritis, osteoarthritis, joint diseases, systemic lupus erythematosus, scleroderma, and complex autoimmune disorders. She treats severe, treatment‑resistant cases using advanced diagnostics and personalized therapy.

She trained in rheumatology and internal medicine at Sheba. She combines patient care with research on new therapies. She served for 12 years as Vice President of the World Association of Rheumatologists. She is Editor‑in‑Chief of Lupus and a member of the Israeli Medical Association and the International Association of Rheumatologists.